| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |